Lung adenocarcinoma was the predominant diagnosis (70.8%, including primary and metastatic lesions), with the remainder representing a spectrum of gastrointestinal, pancreatobiliary, and gynecological carcinomas, large/small cell neuroendocrine carcinomas, and malignant melanoma.